Search Publications by Divisions
and/or by Keywords:  






Latest Public Citizen Publications

Your search returned 812 matches
First 10 records

FDA’s Partial Hold on Unethical Diabetes Drug Trial Does Not Do Enough to Protect Patients (HRG Publication #1916)
The Food and Drug Administration (FDA) has gone only half-way in stopping the unethical TIDE study by halting the recruitment of any new patients. To allow the experiment to continue at all is a major breach in the FDA’s obligation to protect people in clinical trials.
[Created on: 08/17/2010]

Complete Publication>>

Testimony on Rosiglitazone (Avandia) Safety (HRG Publication #1913)
Rosiglitazone (Avandia) compares unfavorably to Pioglitazone (Actos) and should be removed from the market.
[Created on: 08/17/2010]

Complete Publication>>

1914
1914
[Created on: 07/15/2010]

Complete Publication>>

Comments on Direct-to-Consumer Drug Advertising (HRG #1910)
Public Citizen proposes stricter regulations concerning direct-to-consumer drug advertising.
[Created on: 06/28/2010]

Complete Publication>>

Letter Urging FDA to Halt Rosiglitazone (Avandia) Trial (HRG Publication #1908)
We urge the FDA to halt an international diabetes trial that would put patients at unnecessary risk.
[Created on: 05/10/2010]

Complete Publication>>

Testimony of Sidney M. Wolfe, M.D. Director, Health Research Group at Public Citizen Before House Agriculture-FDA Appropriations Subcommittee Hearing on Rosiglitazone (Avandia) (HRG Publication #1907)
Dr. Wolfe explains why the TIDE study must be stopped immediately, and pushes the FDA to ban rosiglitazone (Avandia).
[Created on: 04/28/2010]

Complete Publication>>

Testimony on the Cancer Risk of Calcineurin Inhibitor Skin Medications Tacrolimus (Protopic) and Pimecrolimus (Elidel) (HRG Publication #1904
Sidney Wolfe, M.D. testified about the lymphoma risk posed to children by the ezcema medications tacrolinus (Protopic) and pimecrolimus (Elidel).
[Created on: 03/22/2010]

Complete Publication>>

Letter to FDA Praising Food Safety Cautiousness, Attacking Drug Safety Recklessness (HRG Publication #1903)
In contrast to becoming more active and cautious in enhancing food safety by removing potentially dangerous products before they have caused harm, several FDA decisions in the past year regarding prescription drugs can only be described as reckless.
[Created on: 03/08/2010]

Complete Publication>>

Medical Malpractice Payments Fall Again in 2009
Medical Malpractice Payments Fall Again in 2009
[Created on: 03/03/2010]

Complete Publication>>

Article in Health Matrix: Survey of State Medical and Osteopathy Board Disciplinary Web Sites in 2006 (HRG Publication #1902)
We sought to describe doctor disciplinary information provided on the web sites of state medical and osteopathic boards. Information collected included state board, hospital and federal government actions, as well as malpractice judgments and settlements and conviction information.
[Created on: 02/04/2010]

Complete Publication>>


Next 10>>